Literature DB >> 1280988

Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure.

E M Hodson1, A S Brown, L P Roy, A R Rosenberg.   

Abstract

Insulin-like growth factor-binding protein-3 (IGFBP-3) and insulin-like growth factor-1 (IGF-1) levels were measured by specific radioimmunoassays in children with all degrees of chronic renal failure (CRF). Study group 1 comprised 29 children (10 on dialysis) who had been studied one to four times over 2 years to determine whether IGF-1 and IGFBP-3 levels differed from those in age-matched healthy children and to examine the relationship between these levels and heights. IGF-1 and IGFBP-3 levels did not differ from those in normal children. IGF-1 and IGFBP-3 were significantly correlated, increased with pubertal stage in all children and with age in non-dialysis patients. IGF-1, but not IGFBP-3, correlated with age in dialysis patients. There was no correlation between IGF-1 or IGFBP-3 levels (corrected for age) and height standard deviation score (SDS) in either non-dialysis or dialysis patients. Study group 2 comprised 19 children (7 on dialysis) who were studied prospectively for 1-2 years to examine the relationship between IGF-1 and IGFBP-3 levels, growth rates and nutritional parameters. Mean values of IGF-1 and IGFBP-3 (corrected for age) did not change over 1-year periods, while height SDS fell by -0.38 +/- 0.21 SD/year in dialysis patients and by -0.11 +/- 0.29 SD/year in non-dialysis patients. No significant correlations were found between IGF-1 or IGFBP-3 levels and growth rates or nutritional parameters. Thus growth retardation in children with CRF is not related to circulating levels of IGF-1 or IGFBP-3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280988     DOI: 10.1007/BF00874005

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation.

Authors:  A T Soliman; A E Hassan; M K Aref; R L Hintz; R G Rosenfeld; A D Rogol
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

2.  Revised standards for triceps and subscapular skinfolds in British children.

Authors:  J M Tanner; R H Whitehouse
Journal:  Arch Dis Child       Date:  1975-02       Impact factor: 3.791

Review 3.  Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments.

Authors:  J M Holly; J A Wass
Journal:  J Endocrinol       Date:  1989-09       Impact factor: 4.286

4.  The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro.

Authors:  W M Burch; J Correa; J E Shively; D R Powell
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

5.  Characterization of insulin-like growth factor-binding proteins in human serum from patients with chronic renal failure.

Authors:  F Liu; D R Powell; R L Hintz
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

6.  Somatomedin levels in childhood, adolescence and adult life.

Authors:  K Hall; V R Sara
Journal:  Clin Endocrinol Metab       Date:  1984-03

7.  The simultaneous determination in children of glomerular filtration rate and effective renal plasma flow by the single injection celarance technique.

Authors:  A Donath
Journal:  Acta Paediatr Scand       Date:  1971-09

8.  Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia.

Authors:  W F Blum; M B Ranke; K Kietzmann; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

9.  Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.

Authors:  R C Baxter; A S Brown; J R Turtle
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

10.  Somatomedin in growth disorders and chronic renal insufficiency in children.

Authors:  S L Schwalbe; P R Betts; P H Rayner; B T Rudd
Journal:  Br Med J       Date:  1977-03-12
View more
  2 in total

1.  Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

Authors:  Tetyana L Vasylyeva; Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-03-23       Impact factor: 2.372

2.  Nutritional status of children with moderate chronic renal failure.

Authors:  G Orejas; F Santos; S Málaga; C Rey; A Cobo; M Simarro
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.